New Enterprise Associates 16, L.P., 10% Owner at Regulus Therapeutics Inc. (RGLS), bought 2,273,408 shares at $1.08 ($2.5M) on 2019-05-07, disclosed to the SEC on 2019-05-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.08 | 1,136,704 | $1.2M | 50.0% |
| 2 | $1.08 | 1,136,704 | $1.2M | 50.0% |
| Total | $1.08 avg | 2,273,408 | $2.5M | 100% |
| Filing → |
| MTCR | SELL | 2021-12-27 | $649K | — | Filing → |
| RGLS | BUY | 2020-12-07 | $5.5M | — | Filing → |
| AKUS | BUY | 2020-07-01 | $10.0M | — | Filing → |